Clinical trials
Phase 2 Recurrence trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
408 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 5 |
| 2001 | 8 |
| 2002 | 8 |
| 2003 | 8 |
| 2004 | 12 |
| 2005 | 19 |
| 2006 | 17 |
| 2007 | 20 |
| 2008 | 9 |
| 2009 | 21 |
| 2010 | 27 |
| 2011 | 14 |
| 2012 | 19 |
| 2013 | 13 |
| 2014 | 18 |
| 2015 | 17 |
| 2016 | 10 |
| 2017 | 14 |
| 2018 | 19 |
| 2019 | 6 |
| 2020 | 15 |
| 2021 | 11 |
| 2022 | 13 |
| 2023 | 13 |
| 2024 | 9 |
| 2025 | 14 |
| 2026 | 14 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 231 |
| Terminated | 76 |
| Recruiting | 35 |
| Active, not recruiting | 25 |
| Withdrawn | 19 |
| Unknown status | 12 |
| Not yet recruiting | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fred Hutchinson Cancer Center | 20 |
| Memorial Sloan Kettering Cancer Center | 20 |
| M.D. Anderson Cancer Center | 15 |
| Novartis Pharmaceuticals | 13 |
| Celgene | 10 |
| Massachusetts General Hospital | 9 |
| National Cancer Institute (NCI) | 9 |
| H. Lee Moffitt Cancer Center and Research Institute | 7 |
| University of Arkansas | 7 |
| AstraZeneca | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 408 |
| Multiple Myeloma | 82 |
| Lymphoma | 68 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 65 |
| Lymphoma, Non-Hodgkin | 64 |
| Leukemia, Myeloid, Acute | 63 |
| Hodgkin Disease | 61 |
| Lymphoma, Large B-Cell, Diffuse | 60 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 60 |
| Burkitt Lymphoma | 53 |
Trials
Showing 1 to 25 of 408. Each trial links to its page on Pharma Observatory.
308 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.